Abstract

http://ssrn.com/abstract=964664
 
 

Citations (2)



 
 

Footnotes (173)



 


 



Pharmaceutical Lemons: Innovation and Regulation in the Drug Industry


Ariel Katz


University of Toronto - Faculty of Law


Michigan Telecommunications and Technology Law Review, Vol. 14, No. 1, pp. 1-41, 2007
University of Toronto, Legal Studies Research Paper No. 08-03

Abstract:     
Before a new drug can be marketed the Food and Drug Administration must be satisfied that it is safe and effective. According to conventional wisdom, the cost and delay involved in this process diminish the incentives to invest in the development of new drugs. Accordingly, several reforms aimed at restoring such incentives have been implemented and others have been advocated.

This paper challenges the central argument in the debate on the topic, namely that drug regulation and drug innovation are necessarily at odds with each other. Although intuitively appealing, the argument that drug regulation negatively affects the incentives to innovate does not fully capture the role that regulation plays in this industry. This paper shows that the regulatory framework is not solely a burden imposed on the industry; it also provides a valuable service to the industry.

Specifically, drug regulation provides certification of drug quality. Such certification, which may not be easily achieved by private market-based mechanisms, prevents the market from becoming a market for "lemons". Therefore, rather than decreasing the expected returns to innovation, this aspect of regulation contributes to the value of new drugs and may actually encourage innovation. This point has largely been absent from most cost-benefit analyses of drug regulation, yet without it any discussion of the merits of regulation is incomplete.

Number of Pages in PDF File: 42

Keywords: pharmaceuticals, drugs, FDA, regulation, information asymmetry, innovation, patents

JEL Classification: I18, K23, K32, L51, O34

Accepted Paper Series


Download This Paper

Date posted: February 22, 2007  

Suggested Citation

Katz, Ariel, Pharmaceutical Lemons: Innovation and Regulation in the Drug Industry. Michigan Telecommunications and Technology Law Review, Vol. 14, No. 1, pp. 1-41, 2007; University of Toronto, Legal Studies Research Paper No. 08-03. Available at SSRN: http://ssrn.com/abstract=964664

Contact Information

Ariel Katz (Contact Author)
University of Toronto - Faculty of Law ( email )
78 Queen's Park
Toronto, Ontario M5S 2C5
Canada
416-978-8892 (Phone)
416-978-2648 (Fax)
HOME PAGE: http://www.law.utoronto.ca/faculty/katz

Feedback to SSRN


Paper statistics
Abstract Views: 3,054
Downloads: 497
Download Rank: 30,277
Citations:  2
Footnotes:  173
Paper comments
No comments have been made on this paper

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo2 in 0.296 seconds